Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1996 1
1998 1
1999 1
2003 1
2004 1
2005 2
2006 3
2008 2
2009 1
2012 1
2013 1
2014 1
2015 2
2017 2
2018 3
2019 2
2020 1
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Results by year
Filters applied: . Clear all
Page 1
Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy.
Berkeley RA, Steele LP, Mulder AA, van den Wollenberg DJM, Kottke TJ, Thompson J, Coffey M, Hoeben RC, Vile RG, Melcher A, Ilett EJ. Berkeley RA, et al. Among authors: van den wollenberg djm. Cancer Immunol Res. 2018 Oct;6(10):1161-1173. doi: 10.1158/2326-6066.CIR-18-0309. Epub 2018 Sep 12. Cancer Immunol Res. 2018. PMID: 30209061 Free article.
The human clotting factor VIII cDNA contains an autonomously replicating sequence consensus- and matrix attachment region-like sequence that binds a nuclear factor, represses heterologous gene expression, and mediates the transcriptional effects of sodium butyrate.
Fallaux FJ, Hoeben RC, Cramer SJ, van den Wollenberg DJ, Briët E, van Ormondt H, van Der Eb AJ. Fallaux FJ, et al. Among authors: van den wollenberg dj. Mol Cell Biol. 1996 Aug;16(8):4264-72. doi: 10.1128/MCB.16.8.4264. Mol Cell Biol. 1996. PMID: 8754827 Free PMC article.
Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models.
van de Merbel AF, van der Horst G, van der Mark MH, Bots STF, van den Wollenberg DJM, de Ridder CMA, Stuurman D, Aalders T, Erkens-Schulz S, van Montfoort N, Karthaus WR, Mehra N, Smits M, Schalken JA, van Weerden WM, Hoeben RC, van der Pluijm G. van de Merbel AF, et al. Among authors: van den wollenberg djm. Cancer Gene Ther. 2021 Jun 16. doi: 10.1038/s41417-021-00360-2. Online ahead of print. Cancer Gene Ther. 2021. PMID: 34135475
Arming oncolytic reovirus with GM-CSF gene to enhance immunity.
Kemp V, van den Wollenberg DJM, Camps MGM, van Hall T, Kinderman P, Pronk-van Montfoort N, Hoeben RC. Kemp V, et al. Among authors: van den wollenberg djm. Cancer Gene Ther. 2019 Sep;26(9-10):268-281. doi: 10.1038/s41417-018-0063-9. Epub 2018 Nov 23. Cancer Gene Ther. 2019. PMID: 30467340
Modification of mammalian reoviruses for use as oncolytic agents.
Van Den Wollenberg DJ, Van Den Hengel SK, Dautzenberg IJ, Kranenburg O, Hoeben RC. Van Den Wollenberg DJ, et al. Expert Opin Biol Ther. 2009 Dec;9(12):1509-20. doi: 10.1517/14712590903307370. Expert Opin Biol Ther. 2009. PMID: 19916732 Review.
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy.
Groeneveldt C, Kinderman P, van den Wollenberg DJM, van den Oever RL, Middelburg J, Mustafa DAM, Hoeben RC, van der Burg SH, van Hall T, van Montfoort N. Groeneveldt C, et al. Among authors: van den wollenberg djm. J Immunother Cancer. 2020 Oct;8(2):e001191. doi: 10.1136/jitc-2020-001191. J Immunother Cancer. 2020. PMID: 33082167 Free PMC article.
30 results